This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Impax Laboratories Inc (IPXL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 340.35M 214.87M 184.61M 142.16M
Receivables 324.45M 146.49M 112.99M 92.25M
Inventories 125.58M 80.57M 70.11M 89.76M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 822.07M 730.45M 659.74M 545.54M
Property, Plant & Equipment, Gross 347.30M 304.36M 287.81M 267.52M
Accumulated Depreciation & Depletion 133.14M 116.19M 99.62M 86.76M
Property, Plant & Equipment, Net 214.16M 188.17M 188.19M 180.76M
Intangibles 602.02M 26.71M 29.67M 47.95M
Other Non-Current Assets 73.76M 64.45M 57.82M 42.75M
Total Non-Current Assets 1.10B 348.75M 337.18M 318.43M
Liabilities & Shareholder Equity
Total Assets 1.92B 1.08B 996.92M 863.97M
Accounts Payable 56.33M 31.98M 26.82M 41.34M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 830.00K 15.39M 0.00 1.54M
Total Current Liabilities 326.76M 158.70M 153.89M 145.29M
Long Term Debt 424.60M 0.00 0.00 0.00
Deferred Income Taxes 72.77M 0.00 0.00 0.00
Other Non-Current Liabilities 35.95M 32.62M 32.83M 27.57M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 533.32M 32.62M 32.83M 27.57M
Total Liabilities 860.08M 191.32M 186.72M 172.87M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.06B 887.88M 810.20M 691.10M
Common Par 729.00K 714.00K 699.00K 685.00K
Additional Paid In Capital 504.08M 364.10M 336.65M 314.72M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 570.22M 531.23M 473.87M 372.61M
Treasury Stock -2.16M -2.16M -2.16M -2.16M
Other Equity Adjustments -10.46M -6.01M 1.14M 5.24M
Total Capitalization 1.49B 887.88M 810.20M 691.10M
Total Equity 1.06B 887.88M 810.20M 691.10M
Total Liabilities & Stock Equity 1.92B 1.08B 996.92M 863.97M
Total Common Shares Outstanding 72.68M 71.23M 69.68M 68.27M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 243.73K 243.73K 243.73K 243.73K
Basic Weighted Shares Outstanding 69.64M 68.19M 66.92M 65.66M
Diluted Weighted Shares Outstanding 72.03M 70.53M 68.66M 68.40M
Number of Employees 1290 1061 973 1125
Number of Part-Time Employees 0 0 0 0
IPXL News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

IPXL Impax Laboratories Inc

Chart of IPXL

Analysts Ratings for IPXL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 7 6 6 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 1
GET IPXL ANALYST REPORT

IPXL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs